Are you or a loved one facing ALK-positive cancer?

The ALK Positive Second Opinion Program is designed to support patients and families seeking clarity, guidance, or validation for their treatment plans. The program provides the cost of a consultation with a leading expert in ALK-positive cancer.

What is the ALK Positive Second Opinion Program?

The ALK Positive Second Opinion Program was conceived by a generous ALK Positive member, Jim Peard. and established by the ALK Positive Medical Committee, to provide eligible patients with free access to top-tier oncologists specializing in ALK-positive cancer. This initiative helps patients gain confidence in their treatment plan or explore other therapeutic options tailored to their unique needs.

  • Validate Your Treatment Plan
    Confirm whether your current plan aligns with the latest medical advances.
  • Expand Your Options
    Learn about innovative treatments or clinical trials not previously considered.
  • Peace of Mind
    Feel confident knowing you’ve explored all possible avenues with world-class expertise.
  • World-Class Expertise
    Get insights from the world’s foremost ALK-positive cancer experts affiliated with academic and research institutions.

How Does It Work?

  • Email SOP@alkpositive.org to start the application process.
  • The Second Opinion Program Review Panel will review your application to determine eligibility.
  • If approved, your case will be reviewed by a leading ALK-positive cancer specialist.

This program is open to people navigating ALK-positive cancer who:

  • Is a patient diagnosed with ALK-positive cancer (Care partner may apply on behalf of patient)
  • Face financial barriers to accessing second opinions*

*Note: While the program covers the consultation fee, other associated costs such as travel, accommodation, and additional testing are not included.

To ensure our limited funds are available for those who need them most, we kindly request that applicants who can afford a second opinion not apply to this program.

Patient records are shared with the doctor to facilitate the consultation. Many consultations can be conducted remotely, offering convenience and accessibility—especially for patients who are too unwell to travel, unable to afford accommodations, or unable to take time off work.

Second Opinion Participating Oncologists

The program connects you with leading specialists in ALK-positive cancer treatment from renowned institutions. These professionals are at the forefront of research and treatment innovations, offering invaluable insights into your care.

  • This list can be used even if you are not applying for the Second Opinion Program. Download the list below.
State / CountryTreatment Center, CityDoctorRemote*
Canada
Ontario
Toronto
Princess Margaret Cancer Centre
Dr. Natasha Leighl
Dr. Geoffrey Liu
Yes5
Yes6
India
Karnataka
Banglalore
St. John’s Medical College and Hospital HCG Hospitals

Dr. Govind Babu
TBA
USA
California
San Francisco
UCSF Thoracic Surgery and Oncology Clinic
Dr. Collin BlakelyNo
USA
California
Irvine, Orange County
UC Irvine
Dr. Misako NagasakaNo
USA
California
Duarte, Los Angeles County
City of Hope Cancer Center
Dr. Christine LovlyNo
USA
California
San Diego
UC San Diego
Dr. Hatim HuseinNo
USA
Colorado
Denver
UCHealth
Dr. Ross Camidge
Dr. Tejas Patil
Dr. Erin Schenk
Yes
Yes
No
USA
Florida
Miami
University of Miami Hospital
Dr. Gilberto LopesNo
USA
Florida
Orlando
Advent Health Cancer Center

Dr. Mark Socinski
No
USA
Georgia
Atlanta
Winship Cancer Institute of Emory University
Dr. Shirish GadgeelYes3
USA
Maryland
Baltimore
Johns Hopkins Cancer Center
Dr. Vincent LamNo
USA
Massachusetts
Boston
Dana Farber Cancer Institute
Dr. Narjust Florez
Dr. Alice Shaw
Yes2
No
USA
Massachusetts
Boston
Massachusetts General Hospital
Dr. Jessica Lin & TeamNo
USA
Michigan
Ann Arbor
University of Michigan Health

Dr. Angel Qin
No
USA
Ohio
Columbus
Ohio State University Wexner Medical Center
Dr. Timothy Burns
Dr. David Carbonne
Dr. Christian Diego Rolfo
Yes 1
USA
Oregon
Portland
Knight Cancer Institute, OHSU

Dr. Rajat Thawani
Yes4
USA
New York
New York
Memorial Sloan Kettering Cancer Center

Dr. Mark Awad
No
USA
Tennessee
Nashville
Tennessee Oncology
Dr. Todd BauerNo
USA
Texas
Houston
MD Anderson Cancer Center
Dr. Yasir Elamin
Dr. Carl Gay
Dr. John Heymach
No
No
TBA
USA
Virginia
Fairfax
Virginia Cancer Specialists
Dr. Alex SpiraNo
USA
Washington
Seattle
Fred Hutchinson Cancer Center
Dr. Christina Baik
Dr. Keith Eaton
No
No
USA
Washington, DC
MedStar Georgetown University Hospital
Dr. Stephen Liu
No

*Subject to change
1* US patients can call the number to find out more about the requirements for remote telehealth options
2* Dr. Florez can do remote consultations with patients in Connecticut, Maine, Massachusetts, New Hampshire, Rhode. Island, Vermont and Florida.
3* Dr. Gadgeel can do remote consultations with patients in Michigan and Georgia
4* Dr. Thawani can do remote consultations with patients residing in Oregon
5* Dr. Leighl can do international remote consultations
6* Dr. Liu can do consultations with other oncologists across all of Canada

Here is a list of some prominent nonprofit organizations in the United States that assist cancer patients with travel and accommodation costs, specifically for attending clinical trials or treatment, along with details about their programs:

Air Charity Network: Connects cancer patients with free air transportation for medical treatment, using volunteer pilots and partner airlines.

American Cancer Society (ACS):

•  Hope Lodge: Provides free temporary housing for cancer patients and their caregivers who need to travel for treatment away from home.

•  Extended Stay America Partnership: Collaborates with Extended Stay America to offer discounted or free hotel stays for patients traveling for cancer treatment, according to Cancer Care News.

•  Transportation Grants: Offers local grants to health systems and community organizations to address unmet transportation needs of cancer patients, particularly vulnerable populations.

•  ACS ACTS (Access to Clinical Trials and Support): Provides assistance with finding clinical trials, connecting patients with cancer information specialists, and accessing other ACS programs like lodging and transportation.

CancerCare: Offers financial assistance programs, including transportation grants for patients undergoing active treatment, based on financial need.

Corporate Angel Network (CAN): Offers free flights on corporate and private aircraft for cancer patients, including those traveling for clinical trials. Eligibility is not based on financial need, and patients can travel as often as required.

Healthcare Hospitality Network: A network of nonprofit organizations across the US that offers free or low-cost lodging to families traveling for medical treatment, according to the American Cancer Society.

Lazarex Cancer Foundation: This organization focuses specifically on helping patients find and participate in clinical trials, providing reimbursement for travel costs (airfare, lodging, etc.) for both the patient and a companion for the duration of the trial.

More Moments More Memories: Provides clinical trial expense funding for travel and lodging for cancer patients in the contiguous United States, based on financial need (income limits apply).

Patient Advocate Foundation (PAF): Provides direct financial assistance to patients, including transportation, housing, and food expenses related to cancer treatment, based on eligibility and funding availability.

Sweat for Breath:Provides Hardship Assistance Grants to lower the barrier for ALK+ lung cancer patients in getting a second opinion.

A researcher in a lab looking at a tablet.

Testing for ALK+ Lung Cancer

With biomarker testing, your doctor can find out if your lung cancer is positive for ALK or other gene errors.

A doctor holding a pen talking to a patient.

Treating ALK+ Lung Cancer

Patients today can significantly benefit from targeted therapies that treat ALK+ lung cancer at its source.

A doctor consoling a patient with their hand on the patient's arm.

Just Diagnosed With ALK+?

Learn about managing and adjusting to life with ALK+ lung cancer.